Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil. [Carta] (2024)
- Authors:
- Donadel, Camila Derminio
- De Santis, Gil Cunha
- Gonçalves, Thiago Eleutério
- Pires, Bruno G.
- Palma, Leonardo Carvalho
- Gava, Flavia
- Guerino-Cunha, Renato Luiz
- Faria, Joana Teresa Bisinella de
- Silva, Gabriela Ventura de Almeida
- Darrigo Júnior, Luiz Guilherme
- Fatobene, Giancarlo
- Rocha, Vanderson Geraldo
- Covas, Dimas Tadeu
- Calado, Rodrigo Tocantins
- Clé, Diego Villa
- USP affiliated authors: SANTIS, GIL CUNHA DE - FMRP ; PALMA, LEONARDO CARVALHO - FMRP ; CUNHA, RENATO LUIZ GUERINO - FMRP ; DARRIGO JUNIOR, LUIZ GUILHERME - FMRP ; ROCHA, VANDERSON GERALDO - FM ; COVAS, DIMAS TADEU - FMRP ; RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP ; CLÉ, DIEGO VILLA - FMRP ; GONÇALVES, THIAGO ELEUTERIO - FMRP ; FARIA, JOANA TERESA BISINELLA DE - FMRP ; SILVA, GABRIELA VENTURA DE ALMEIDA - FMRP
- Unidades: FMRP; FM
- DOI: 10.1038/s41409-024-02283-6
- Subjects: LEUCEMIA; GENÉTICA; LINFOMA; IMUNOTERAPIA; LINFÓCITOS T; NEOPLASIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Bone Marrow Transplantation
- ISSN: 0268-3369
- Volume/Número/Paginação/Ano: v. 59, n. 7, p. 1040-1042, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DONADEL, Camila Derminio et al. Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil. [Carta]. Bone Marrow Transplantation, v. 59, n. 7, p. 1040-1042, 2024Tradução . . Disponível em: https://doi.org/10.1038/s41409-024-02283-6. Acesso em: 31 jan. 2026. -
APA
Donadel, C. D., De Santis, G. C., Gonçalves, T. E., Pires, B. G., Palma, L. C., Gava, F., et al. (2024). Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil. [Carta]. Bone Marrow Transplantation, 59( 7), 1040-1042. doi:10.1038/s41409-024-02283-6 -
NLM
Donadel CD, De Santis GC, Gonçalves TE, Pires BG, Palma LC, Gava F, Guerino-Cunha RL, Faria JTB de, Silva GV de A, Darrigo Júnior LG, Fatobene G, Rocha VG, Covas DT, Calado RT, Clé DV. Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil. [Carta] [Internet]. Bone Marrow Transplantation. 2024 ; 59( 7): 1040-1042.[citado 2026 jan. 31 ] Available from: https://doi.org/10.1038/s41409-024-02283-6 -
Vancouver
Donadel CD, De Santis GC, Gonçalves TE, Pires BG, Palma LC, Gava F, Guerino-Cunha RL, Faria JTB de, Silva GV de A, Darrigo Júnior LG, Fatobene G, Rocha VG, Covas DT, Calado RT, Clé DV. Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil. [Carta] [Internet]. Bone Marrow Transplantation. 2024 ; 59( 7): 1040-1042.[citado 2026 jan. 31 ] Available from: https://doi.org/10.1038/s41409-024-02283-6 - Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells.: III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
- Cryopreservation impairs engraftment in bone marrow transplantation
- Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V. Special article: manufacture and quality control
- Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients
- Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation
- Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia
- Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation
- Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: accreditation process
- Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease
- Impacto da incompatibilidade ABO no transplante de células progenitoras hematopoiéticas em pacientes pediátricos
Informações sobre o DOI: 10.1038/s41409-024-02283-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
